Lung infections due to Pseudomonas aeruginosa and Pseudomonas cepacia are common in patients with cystic fibrosis. Initial colonization is due to nonmucoid P. aeruginosa, while later mucoid variants emerge and are associated with chronic infection. P. cepacia colonization tends to be more prevalent in older patients. The present study was conducted to discover whether highly purified mucins (from cystic fibrosis sputum and control intestinal secretions) exhibited specific binding of nonmucoid P. aeruginosa. In vitro solid phase microtiter binding assays (with or without a blocking agent) as well as solution phase assays were conducted. Bacteria bound to both mucins via bacterial pili, but no differences in binding capacity were noted between the mucins. Unlike P. cepacia (described in the accompanying manuscript) there was also no (5) reported that P. aeruginosa bind to N-acetylgalactosamine (GalNAc)' f 1,4 galactose (Gal) sequences of asialo-GM 1 and asialo-GM2 gangliosides. Baker et al. (6) have also shown positive binding to Gal 3 1,4 glucose (Glc) 3 1-Ceramide, whereas Doig et al. (7) suggest a role for one or more cell surface glycoproteins as receptors. Although respiratory cells bind P. aeruginosa in vitro, some doubts about the relative importance in vivo of bacterial-cell interactions have been raised. For example, immunohistopathological studies of Baltimore et al. (8) have demonstrated that in autopsy specimens of cystic fibrosis (CF) lungs, P. aeruginosa are almost always found associated with stagnant luminal mucus and exudates rather than attached to mucosal surfaces. Nelson et al. (9) have shown adherence in vitro of P. aeruginosa to mucin monolayers, and Plotkowski et al. (10) employing a frog palate model, found that P. aeruginosa attached preferentially to serosal rather than mucosal surfaces, and to patches of luminal mucus rather than to mucosal cell surfaces.
colonization with Pseudomonas aeruginosa. The initial colonization is with nonmucoid P. aeruginosa, while later, variants expressing a mucoid form emerge and are associated with chronic pulmonary infection. Little is known about the selective bacterial-host interactions which establish the initial colonization, although in vitro studies have demonstrated the adherence of nonmucoid P. aeruginosa to respiratory epithelial cells, and the involvement of bacterial pili as adhesins (1) (2) (3) (4) . Pilin proteins have been isolated and sequenced from well characterized nonmucoid strains PAO 1 and PAK, and the binding domains localized to COOH-terminal regions of the proteins (3, 4) . Monoclonal antibodies against specific COOHterminal domains (e.g., PK34C for PAK pili) effectively inhibit PAOl and PAK pili binding to buccal cells (4) . Much less is known, however, concerning epithelial cell receptors for P. aeruginosa, although suggestions have been made that cell surface glycolipids and/or glycoproteins may be important for the binding ofPseudomonas pili. Krivan et al. (5) reported that P. aeruginosa bind to N-acetylgalactosamine (GalNAc)' f 1,4 galactose (Gal) sequences of asialo-GM 1 and asialo-GM2 gangliosides. Baker et al. (6) have also shown positive binding to Gal 3 1,4 glucose (Glc) 3 1-Ceramide, whereas Doig et al. (7) suggest a role for one or more cell surface glycoproteins as receptors.
Although respiratory cells bind P. aeruginosa in vitro, some doubts about the relative importance in vivo of bacterial-cell interactions have been raised. For example, immunohistopathological studies of Baltimore et al. (8) have demonstrated that in autopsy specimens of cystic fibrosis (CF) lungs, P. aeruginosa are almost always found associated with stagnant luminal mucus and exudates rather than attached to mucosal surfaces. Nelson et al. (9) have shown adherence in vitro of P. aeruginosa to mucin monolayers, and Plotkowski et al. (10) employing a frog palate model, found that P. aeruginosa attached preferentially to serosal rather than mucosal surfaces, and to patches of luminal mucus rather than to mucosal cell surfaces.
In vitro microtiter well binding assays by Viswanath and Ramphal (11, 12) and Ramphal et al. (13) have demonstrated adherence of piliated P. aeruginosa to preparations of respiratory mucin, an association that they suggest depends upon specific carbohydrate receptor sites in respiratory mucins. They have also reported that mucins interfere with the binding of these bacteria to respiratory cells; and on this basis, propose that the association between P. aeruginosa and mucin is specific, and that mucin represents the preferential colonization site in the airways of patients with cystis fibrosis.
Although these are attractive proposals, they have been somewhat difficult to reconcile with the earlier data of Paran- 1. Abbreviations used in this paper: BEC, buccal epithelial cells; CF, cystic fibrosis; Gal, galactose; GalNAc, N-acetylgalactosamine; Glc, glucose; GlcNAc, N-acetylglucosamine; RT, room temperature; SIM, small intestinal mucin; TBM, tracheobronchial mucin; TMU, tetramethylurea. chych et al. (14) who showed that pili of PAK strain bound nonspecifically to a whole host of structurally unrelated proteins and glycoproteins. No particular role for carbohydrates as receptor molecules could be demonstrated in a large series of BSA-sugar conjugates. Thus the role ofadhesion ofP. aeruginosa to mucins, the relative affinity of mucins versus other proteins, glycoproteins or glycolipids (including cell surface structures) for these organisms, and the early colonization events in Pseudomonas infection in CF still remain controversial.
This study was undertaken in an effort to discover whether highly purified mucins (from CF sputum and non-CF intestine) exhibited receptor-mediated binding interactions with nonmucoid strains of P. aeruginosa. In solid phase assays we measured radioactively labelled bacteria binding to immobilized mucins, and in solution phase assays we measured radiolabelled mucin binding to bacteria. The nature and the extent of mucin-bacterial interactions differed under the two assay conditions used, although in both cases hydrophobic interactions with the pili of P. aeruginosa were involved. Neither assay, however, gave any evidence to support the existence of preferential high affinity receptor sites on mucins for the attachment of pili when binding to mucin was compared with binding to other proteins.
Our data do not encourage us, therefore, to construct models of pathogenesis in which the key initial step depends upon a specific receptor site on mucins for adherence ofP. aeruginosa. Our findings contrast sharply with those reported in the accompanying paper for the interactions of mucins with Pseudomonas cepacia.
Methods
Bacterial strains and culture conditions P. aeruginosa (nonmucoid) strains, PAO1, PAK, P1, and HD1 were kindly provided by Dr. W. Paranchych, Department of Microbiology, University of Alberta, Edmonton. Strain K122-4 was supplied by Dr. P. Flemming, Department of Bacteriology, Hospital for Sick Children, Toronto. These strains have been well described in previous publications (15) (16) (17) . Three other clinical isolates (PANMI, PANM2, and PANM3) were isolated from sputum samples of hospitalized cystic fibrosis patients, and were kindly supplied by Dr. M. Karmali, Division of Microbiology, Hospital for Sick Children, Toronto. All strains were maintained on brain heart infusion agar slants at -70°C. In preparation for binding assays, a single colony was inoculated into M9 medium, incubated overnight at 37°C in a gyroshaker (at 150 rpm; New Brunswick Scientific Co., Inc., Edison, NJ), an aliquot (1 ml) transferred into fresh M9 medium (9 ml), incubated 3 800 Ci/mmol). After a further 3-h incubation, the bacteria were harvested by centrifugation ( 12,000 g for 10 min at 4°C), washed three times with PBS pH 7.2, and suspended in the same buffer to give the desired concentration (0.1 OD U at 650 nm was equal to 3 X 108 CFU/ml). Further details of this method are described by McEachran and Irvin (18) .
Purification of tracheobronchial (TBM) and small intestinal (SIM) mucins TBM was purified from sputum samples of hospitalized CF patients during treatment oflung infection, following the method ofCarlstedt et al. (19) with minor modifications. Within 30 min of expectoration, individual sputum samples were mixed with PBS pH 7.2 containing guanidine hydrochloride, (4 M), PMSF (2 mM), N-ethylmaleimide (5 mM), Na2EDTA (5 mM), and NaN3 (0.02% vol/vol). Samples were pooled and centrifuged at 2,000 g for 15 min at 40C, and the mucous gel pellet redissolved in the same mixture and homogenized in a blender (Waring, New Hartford, CT) for 30 s. After centrifugation at 27,000 g at 40C for 30 min to remove cell debris, the supernatant was subjected to two sequential CsCl density gradient ultracentrifugations in the presence of 4 M and then 0.2 M GnHCl. The final periodic acid/Schiff-positive mucin fractions (20) were pooled (buoyant density p 1.36-1.41 g/ml), dialyzed against distilled H20, and stored at -200C before use.
Human SIM was isolated from small intestinal secretions ofa single adult patient who had received an intestinal bypass operation (jejunoileal anastomosis) for the treatment of gross obesity. During a second operation one year later, the distal anastomosis was severed and small intestinal secretions drained through a surgical fistula into an ileostomy bag attached to the abdominal wall. These were collected every 12 h for 10 d. PMSF (final concentration 2 mM) was added to each collection bag and the mixture stored at -20'C before our experiments were performed. Since the small bowel remained ligated at the proximal (jejunal) end during the collection, the secretions were uncontaminated by food, bile, pancreatic juice, or gastric contents. Secretions were pooled, dialyzed at 40C against PBS pH 7.2 containing PMSF (2 mM), Na2EDTA (10 mM), NEM (10 mM), and NaN3 (0.02%). The retentate was concentrated 10-fold by a Diaflo apparatus (Amicon, Beverly, MA) (membrane exclusion limit 100 kD), and then subjected to two sequential CsCl density gradient ultracentrifugation steps as described previously (21, 22 (24) , thin layer chromatography for detection of glycolipids (25) , and immunoassay for fibronectin (26) . Both mucin preparations gave compositions which were almost identical with those published earlier for purified TBM (26) and SIM (21, 22) with the exception of sugar composition of SIM. The N-acetylglucosamine (GlcNAc)/GalNAc ratio was slightly higher and sialic acid concentration was somewhat lower than usual. It is possible that some degradation of the mucin occurred prior to purification because the secreted mucin was exposed to other ileal secretions (but no bacteria) for several hours before purification procedures were initiated. Despite these considerations, the mucin was used extensively in this study because it wasjudged to be reasonably normal and was available in high quantity (unlike TBM) and because it behaved almost identically to TBM with respect to bacterial binding. Both TBM and SIM were free of contaminants such as fibronectin and glycolipids.
Iodination ofmucin
Small intestinal mucin (I100 ,ug protein) was iodinated using iodobeads (Pierce Chem. Co., Rockford, IL), and passed through Sephadex G-25 (Pharmacia, Uppsala, Sweden) to remove free '25I, as described by Chadee et al. (27) . Labelled mucin was then mixed with nonradioactive mucin (1:20 vol/vol), and the protein concentration was measured by using the bicinchonic acid assay (28 Solution phase assays to measure mucin binding to bacteria For these assays much larger amounts of mucin were required, and therefore most experiments were performed using SIM rather than TBM, since the former was available in much greater quantity. 125I-labelled SIM (0.5 ml PBS containing 1.4-14.6 Mg mucin protein) was mixed with 0.5 ml ofP. aeruginosa (final concentration 9 X 108 cell/ml of PBS) at pH 7.2, and incubated for 1 h at 37°C. The mixture was centrifuged for 3 min at 12,000 g at room temperature (RT), the bacterial pellet washed 10 times with PBS; and bound mucin counted in a -y-counter (8000; Beckman Instruments, Inc., Fullerton, CA). Background (nonspecific) binding was calculated by measuring the radioactive mucin bound to Escherichia coli serotype 01 57:H7 strain CL-49 (nonpiliated form), a strain known not to bind to mucin (31) . Other controls consisted of using free '25Iodine instead of 251I-labelled mucin in incubations with bacteria. In each case, background binding was < 15% of test samples.
Hapten inhibition studies
In solid phase assays potential haptens (proteins, carbohydrates) were preincubated for 1 h at 370C with 3H-labelled P. aeruginosa (108 cells/ ml) and the mixture then added to mucin-coated or BSA-coated wells.
In solution phase assays, haptens were also preincubated with P.
aeruginosa (I 09 cells/ml), and then 1251-labelled mucin (1 1.68 Mg mucin protein/0.5 ml PBS) was added to the mixture. The remaining steps of each binding assay were as described above.
In experiments in which purified PAK or PAOl pili were used as haptens, the pili were preincubated (1 h, 37°C) with mucin samples rather than bacteria. For solid phase assays the preincubation was followed by three washes with PBS to remove unbound pili, and the binding assay then carried out as usual. In solution phase assays, the preincubation mixture was added to bacteria and the binding assay continued as usual.
Binding ofPAOJ and PAK bacteria to buccal epithelial
The Fig. 1 (1 1). In the hopes that these assay conditions might permit further characterization ofbinding specificity of mucin versus BSA, we carried out inhibition experiments through this "window", namely, in the presence of a low concentration (2-4 X 108 CFU/ml) of added bacteria.
(c) Hapten inhibition in solidphase assays (without a blocking agent). As shown in Table II mechanism of enhancement was not further explored since it was clear from these experiments that specific hapten inhibition had not been demonstrated. There was, in particular, no evidence to support the notion that a mucin receptor for P. aeruginosa relied upon sialic acid, N-acetylglucosamine, or the Fig. 2 , A and B, shows that many structurally unrelated compounds caused inhibition, but they produced almost identical concentration-dependent inhibition profiles for both TBM and BSA.
Some proteins actually caused enhanced binding (pepsin and cytochrome c) and BSA gave a biphasic response. These results are difficult to interpret, but are reminiscent of the earlier data ofParanchych et al. (14) who noted the binding ofPAK pili to a wide variety of proteins immobilized in microtiter wells. Our data probably reflect a combination of protein-induced bacterial aggregation, nonspecific inhibition and/or variable adhesion of protein-bacterial complexes to "free" (nonblocked) sites in the microtiter wells. Importantly however, we were not able to discern a difference in the action ofany ofthese proteins on BSA binding versus mucin binding of P. aeruginosa.
( Fig. 3 . Binding was saturable with increasing mucin concentration (Fig. 3 a) and inhibited by the addition of nonradioactive mucins (SIM, TBM). Thus mucin binding was an equilibrium process and saturation indicated the involvement of a finite number of bacterial attachment sites. A Langmuir adsorption isotherm (Fig. 3 b) gave a linear plot (correlation coefficient, r = 0.946) suggestive of a single type of noninteracting bacterial adhesion sites. The association constant, K, was 0.473±0.071 ml/jig mucin and the total number of available sites for mucin (N) was 3.902±0.353 x 10-'°,g/cell.
By converting the N value to units of bacterial cells bound per micrograms of mucin, a value of 6.41 X 10" bacterial cells would be expected to be able to bind at saturation to 5 ,ug (as protein) of mucin. This represents much more binding (three orders of magnitude) than was ever obtained in solid phase assays. (Fig. 1 shows that the maximum binding was 1.2 X 107 CFU/well). Thus mucin in solution appeared to be much more effective than immobilized mucin in adhering to bacteria.
(a) Effect oftetramethylurea in solution phase assays. The nature of P. aeruginosa-mucin interactions also differed from that observed in solid phase assays, since TMU was only able to diminish binding by 37% (Table III, added to '251-mucin in solution on binding either to enhance whereas all of the proteins com] (Fig. 4) . The most potent inhi which caused 80% inhibition centration (-10-12 sg/ml) as ti (1 1.6 Mg/ml). Since BSA is free that mucin carbohydrate structi Several other proteins were als4
Bacterial adhesinsfor mucin
Since pili on P. aeruginosa mediate the attachment of bacteria to epithelial cells (1-3), we sought evidence for the involvement of the same structures in adherence to mucin and BSA.
Both solid and solution phase assays were used, with the use of purified PAOI and PAK pili as potential hapten inhibitors. In the first set of experiments (solid phase assays without a blocking agent) purified pili were preincubated with mucin or BSA
(1 h at 37QC) in microtiter wells, nonbound pili were removed by washing, and 3H-labelled bacteria then added and binding measured. In a second set of experiments (solution phase assays) pill were preincubated with '251-mucin in solution (1 h at 370C) before the addition of nonradioactive bacteria. Fig. 5 , a and b, shows that purified pili inhibited mucin-bacterial (and BSA-bacterial) interactions in both cases, giving the highest percentage inhibition (80% with PAOl pili) in solution phase afi assays (Fig. 5 b) . Saturation was not achieved. In solid phase 1 0 1 5 2 0 assays (Fig. 5 a) no more than 60% inhibition ofbinding could Ig/mi) be achieved even at saturation.
Direct binding studies of pili to immobilized mucin and d mucin to PAO1. '251-labelled BSA (in microtiter wells) were also performed. (40) who demonstrated the importance of hydrophobic bond-breaking agents in the inhibition of haemagglutination by several strains of P. aeruginosa. In sharp contrast to P. aeruginosa, many clinical isolates of P. cepacia which are described in the next paper, showed significant binding to mucins, and these interactions were not affected by high concentrations of tetramethylurea.
No specific binding role for mucin mono-or oligosaccharides in P. aeruginosa adherence was suggested by the results of hapten inhibition experiments, even for the sequence Gal , 1,4 GlcNAc which has been reported (13) ularly those containing the sequence GalNAc 3 1,4 Gal) have specific receptor activity for nonmucoid P. aeruginosa, it is possible that the mucin binding described by Ramphal et al. (13) was due to contaminating glycolipids in the 'whole' (i.e., impure) mucins employed. Indeed, these investigators have themselves suggested recently that cellular glycolipids that are shed into airway mucus secretions, may contribute significantly to bacterial binding (36).
Solution phase assays to examine mucin binding to Pseudomonas aeruginosa were useful because they eliminated both the need for a blocking agent and the anomalies encountered in hapten inhibition studies performed in solid phase assays in the absence ofa blocking agent. The solution phase assays revealed that mucin bound to a finite set ofbacterial receptors, but once again no evidence for a specific mucin ligand was obtained. That is, carbohydrates did not inhibit binding and many structurally dissimilar proteins (including BSA) were able to compete effectively with mucin. These findings are qualitatively similar to those reported by Paranchych et al. (14) in which pure PAK pili were shown to bind in varying degrees to a host of different proteins, but not to 38 different BSA-carbohydrate conjugates.
An interesting feature of the solution phase assays in this study was that the extent of mucin-bacterial adherence was much greater than that obtained in solid phase assays, and the interaction was not due entirely to weak nonspecific hydrophobic interactions. The potency of inhibitory proteins did not correlate with their net hydrophobicity. We assume that mucin in solution is conformationally more flexible than it is when immobilized in microtiter wells, and thus coats bacteria more easily or makes contact with bacterial binding sites more readily.
In keeping with the findings of Ramphal et al. (42) our studies suggest strongly that pili on P. aeruginosa are important, although perhaps not the sole agent responsible for bacterial interactions with mucins. Pili were able to cause partial inhibition of binding in solid, and especially in solution, phase assays, and direct pili-binding experiments confirmed that PAK and PAOl pili could bind to mucin. Importantly however, we showed that pili bind almost as well to BSA as to mucin, thereby confirming that no strong preference for mucin exists. by washing with PBS. 3H-bacteria (2.5 X i0' cells/ml) were then added and the assay was continued as described under Earlier experiments by Ramphal and Pyle (38) demonstrated that crude mucins prevented the adherence of mucoid and nonmucoid P. aeruginosa to injured tracheal epithelium ofmice. As a result, Ramphal and Vishwanath (39) have speculated that respiratory cells of CF patients do not initially become colonized by P. aeruginosa; rather, it is mucin that is the major initial attractant. Our own experiments in which we measured the binding of P. aeruginosa and isolated pili to BECs, used highly purified respiratory and intestinal mucins as potential inhibitors. We did not observe a decrease in bacterial binding to BECs even with extraordinarily high concentrations of mucins (50 and 100 ;ig [as protein] per ml). We assume that the difference between our results and those of Ramphal and Vishwanath (39) is due to a greater purity ofour mucin preparations.
The COOH-terminal domains ofPAK and PAOI pilin proteins are known to be of prime importance in attaching these strains ofP. aeruginosa to BECs, and adherence can be blocked by the MAb PK34C (4) which is specific for the PAK pili binding domain. However, bacterial binding to mucin or BSA in the present solid phase experiments was not altered by preincubation ofthe bacteria with PK34C. Therefore we conclude that other domains of the pilin protein must be required for bacterial attachment to mucin and BSA. In view of the effects of TMU to abolish binding, the highly hydrophobic NH2-terminal region, which is conserved amongst all P. aeruginosa strains (43) , may play a role in nonspecific attachment of pili to a host of unrelated substrates.
Implicationsfor the development oflung infections in cystic fibrosis. With increasing age of patients with cystic fibrosis, P.
aeruginosa predominate in the lung and are associated with progressive chronic respiratory infection. However, the bio- logic basis of the initial pathologic interaction between this microbe and the CF host remains obscure (44) . Because we were unable in this study to demonstrate a selective or specific binding of nonmucoid P. aeruginosa to purified normal or CF mucins, we feel that some features of the hypothesis of Ramphal and Vishwanath (39) may require revision. This is particularly true of the notion that specific adherence of pili to carbohydrates of mucin is responsible for a 'selective tropism' of P. aeruginosa for the respiratory tract in cystic fibrosis.
